Trevena Inc (TRVN)
0.40
-0.01
(-2.20%)
USD |
NASDAQ |
Apr 26, 16:00
0.40
0.00 (0.00%)
After-Hours: 20:00
Trevena Debt to Equity Ratio: -4.024 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.024 |
| September 30, 2023 | 8.352 |
| June 30, 2023 | 1.449 |
| March 31, 2023 | 1.327 |
| December 31, 2022 | 0.861 |
| September 30, 2022 | 0.619 |
| June 30, 2022 | 0.3748 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.1675 |
| September 30, 2019 | 0.2359 |
| June 30, 2019 | 0.2656 |
| March 31, 2019 | 0.3089 |
| December 31, 2018 | 0.4184 |
| September 30, 2018 | 0.419 |
| June 30, 2018 | 0.6039 |
| Date | Value |
|---|---|
| March 31, 2018 | 0.6899 |
| December 31, 2017 | 0.8128 |
| September 30, 2017 | 0.5996 |
| June 30, 2017 | 0.5033 |
| March 31, 2017 | 0.4147 |
| December 31, 2016 | 0.233 |
| September 30, 2016 | 0.1972 |
| June 30, 2016 | 0.1508 |
| March 31, 2016 | 0.1314 |
| December 31, 2015 | 0.1271 |
| September 30, 2015 | 0.0113 |
| June 30, 2015 | 0.0189 |
| March 31, 2015 | 0.0197 |
| December 31, 2014 | 0.0171 |
| September 30, 2014 | 0.0276 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | |
| December 31, 2012 | -124.25 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-4.024
Minimum
Dec 2023
8.352
Maximum
Sep 2023
0.5068
Average
--
Median
Mar 2020
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 40.60M |
| Total Liabilities (Quarterly) | 48.26M |
| Shareholders Equity (Quarterly) | -7.657M |
| Current Ratio | 4.660 |
| Net Debt Paydown Yield | -27.68% |